Molecular diagnostics specialist Cepheid is bringing its Xperience mobile virtual laboratory to the UK, showcasing the advantages of the company’s innovative GeneXpert technology.
Molecular diagnostics provides optimum sensitivity and speed for pathogen identification and susceptibility testing, and the Cepheid’s GeneXpert systems offer fully automated, on-demand molecular testing in a scalable and easy to use format.
The Cepheid Xperience is currently touring England and Northern Ireland, giving hospital staff – from laboratory technicians and clinicians to chief executives and finance directors – the chance to explore the potential benefits of this technology for their own hospitals, from improving turnaround times and streamlining patient pathways to helping combat antibiotic resistance. This series of events coincides with the release of the 'Tackling Drug-Resistant Infections Globally' report by Lord Jim O’Neill, which contains the latest recommendations on rapid diagnostics and reducing the unnecessary use of antimicrobials.
The Cepheid Xperience gives healthcare professionals a perfect opportunity to discover how GeneXpert technology can help them to tackle antimicrobial resistance and improve the delivery of patient care.
For more information, visit www.cepheidinternational.com
